Analytical method for monitoring concentrations of cyclosporin and lovastatin in vitro in an everted rat intestinal sac absorption model

被引:16
作者
Sharma, P [1 ]
Chawla, HPS [1 ]
Panchagnula, R [1 ]
机构
[1] NIPER, Dept Pharmaceut, Punjab 160062, India
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2002年 / 768卷 / 02期
关键词
cyclosporin; lovastatin;
D O I
10.1016/S1570-0232(02)00005-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cyclosporin A (CSA) and lovastatin (LV) are lipophilic drugs, which show poor and erratic absorption when administered perorally. The permeability of these compounds can be increased transiently by altering the membrane characteristics of the absorptive epithelium by the use of sorption promoters (SPs). In the present work a simple validated HPLC method utilizing an isocratic mobile phase with short retention times for CSA and LV was developed in order to monitor their concentrations in Kreb's Ringer bicarbonate (KRB) solution in vitro in intestinal sac absorption model. The same method was utilized to determine the apparent permeability coefficients and absorption profiles of CSA and LV by a modified Wilson-Wiseman method. Drugs were analysed by a reversed-phase HPLC method using a Shim-pack C-18 column. An isocratic mobile phase containing acetonitrile and water in the proportions 70:30 and 80:20 was used for the HPLC analysis of CSA and LV, respectively. The flow-rate was 2 ml/min and quantitative determinations were carried out at 215 nm at 70 degreesC for CSA. In the case of LV the flow-rate was 1 ml/min and detection was done at 238 run at 25 degreesC. The method was found to be specific as none of the proposed SPs, components of KRB or intestinal sac artefacts interfered with the drug peaks. Recovery studies and intra- and inter-day variations were within statistical limits. The limits of detection were 250 and 10 ng/ml and the limits of quantitation were 400 and 30 ng/ml for CSA and LV, respectively. The calibration curve was found to be linear in concentration range of 0.5-6 mug/ml for CSA and 0.05-0.4 mug/ml for LV. The proposed method was found to be rapid and selective and hence can be applied for continuous monitoring of CSA and LV in vitro in intestinal sac absorption studies. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:349 / 359
页数:11
相关论文
共 20 条
[1]   MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].
ALBERTS, AW ;
CHEN, J ;
KURON, G ;
HUNT, V ;
HUFF, J ;
HOFFMAN, C ;
ROTHROCK, J ;
LOPEZ, M ;
JOSHUA, H ;
HARRIS, E ;
PATCHETT, A ;
MONAGHAN, R ;
CURRIE, S ;
STAPLEY, E ;
ALBERSSCHONBERG, G ;
HENSENS, O ;
HIRSHFIELD, J ;
HOOGSTEEN, K ;
LIESCH, J ;
SPRINGER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961
[2]  
[Anonymous], [No title captured]
[3]   BISPHOSPHONATES INCREASE TIGHT JUNCTION PERMEABILITY IN THE HUMAN INTESTINAL EPITHELIAL (CACO-2) MODEL [J].
BOULENC, X ;
ROQUES, C ;
JOYEUX, H ;
BERGER, Y ;
FABRE, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 123 (01) :13-24
[4]   INVESTIGATION OF THE MECHANISM OF PEAK BROADENING OBSERVED IN THE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF CYCLOSPORINE [J].
BOWERS, LD ;
MATHEWS, SE .
JOURNAL OF CHROMATOGRAPHY, 1985, 333 (01) :231-238
[5]   ADVANCES IN THEORY OF PLATE HEIGHT IN GAS CHROMATOGRAPHY [J].
GIDDINGS, JC .
ANALYTICAL CHEMISTRY, 1963, 35 (04) :439-&
[7]  
KEYOMARSI K, 1991, CANCER RES, V51, P3602
[8]   Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors - Similarities and differences [J].
Lennernas, H ;
Fager, G .
CLINICAL PHARMACOKINETICS, 1997, 32 (05) :403-425
[9]   Concentration- and region-dependent intestinal permeability of fluvastatin in the rat [J].
Lindahl, A ;
Sandström, R ;
Ungell, AL ;
Lennernäs, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (07) :737-744
[10]  
MAURER HH, 1991, ARZNEIMITTEL-FORSCH, V41-1, P104